ARTICLE | Company News
FDA schedules panel meeting for UTHR
June 26, 2001 7:00 AM UTC
The FDA's Cardiovascular and Renal Drugs Advisory Committee will review on Aug. 9 or 10 United Therapeutics' NDA for Remodulin prostacyclin analog to treat pulmonary arterial hypertension. In April, t...